By FMTeam When we talk about Indian pharmaceutical brands that grew steadily and went global, Glenmark Pharmaceuticals is a name that quietly stands tall. The brand has been supplying medicines for decades, but how much do we really know about the company behind the name?Here’s a short and clear look at Glenmark Pharmaceuticals Ltd.—its net worth, ownership, leadership, and direction for the future.
| Company Name | Glenmark Pharmaceuticals Limited |
| Founded | 18 November 1977 |
| Headquarters | Mumbai, India |
| CEO / MD | Glenn Saldanha (MD & Chairman) |
| Industry | Pharmaceuticals |
| Number of employees | 15,556 (Till 2023) |
| Revenue | ₹13,321 crore |
| Net income | ₹1,047 crore (US$120 million) (2025) |
| Ownership Type | Public Limited |
About Glenmark Pharmaceuticals
Glenmark was founded in 1977 by Gracias Saldanha, who named the company after his two sons, Glenn and Mark.The company began as a small operation making basic medicines and their ingredients, and it has since grown into a major drug company that operates all over the world.Over time, Glenmark expanded into multiple therapeutic segments, including dermatology, respiratory care, oncology, cardiology, diabetes, and anti-infective medicines.
Today, its products are sold in 80+ countries, supported by manufacturing and research facilities across the world. The company’s main headquarters is located in Mumbai, Maharashtra.
Financials & Net Worth
In the pharma sector, market capitalization is a practical measure of value. As of 2025 its revenue is ₹13,321 crore (US$1.6 billion). Its netincome is ₹1,047 crore (US$120 million) (2025).As of late 2025, Glenmark’s market cap stands at around ₹53,000 crore, showing its steady presence in the global pharma market.
Future Outlook
So, what’s Glenmark up to? Basically, they’re trying to grow by focusing on innovation.They’re not just sticking to the affordable stuff, like generic drugs (the copies of famous medicines) and OTC products (things you can buy off the shelf without a prescription).
The company is smart because they see two big opportunities: The world needs more and better healthcare. Specific areas like breathing problems and skin issues are growing markets.